A theme aimed at commercializing new businesses by advancing applied research on NDS, including Nose-to-Brain technologies, and exploring personalized medicine approaches based on human genetic analysis. In SNLD development, drug efficacy has been confirmed and proof of concept (POC) obtained in an exploratory Phase II trial.